Cholesterol News From Medical News Today
Latest Cholesterol News From Medical News Today.
- Last build:
- Language:
- en-us
- Feed URL:
- http://www.medicalnewstoday.com/rss/cholesterol.xml
RSS FEED IDEMS: Cholesterol News From Medical News Today
- Physicians And Patients Nationwide Discuss Controversial Results Of Recent Cholesterol Lowering Study
Sermo (http://www.sermo.com), the largest physician-only online community, today announced the results of a physician survey prompted by the swirl of media coverage following the release of ENHANCE trial data at the recent American College of Cardiology (ACC) conference. The focus of the study was on the effectiveness of frequently prescribed cholesterol-lowering drugs, Vytorin and Zetia.
Fri, 11 Apr 2008 03:00:00 PDT - Cholesterol, Blood Pressure Control May Reverse Atherosclerosis In Adults With Diabetes
Aggressively lowering cholesterol and blood pressure levels below current targets in adults with type 2 diabetes may help to prevent - and possibly reverse - hardening of the arteries, according to new research supported by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health. Hardening of the arteries, also known as atherosclerosis, is the number one cause of heart disease and can lead to heart attack, stroke, and death.
Thu, 10 Apr 2008 02:00:00 PDT - eFoodSafety Launches Cinnechol(TM), An All-Natural Alternative To Conventional Cholesterol Drugs
eFoodSafety.com (OTCBB: EFSF, http://www.efoodsafety.com), a researcher, developer, and marketer of whole food nutraceutical products, has launched an all-natural supplement, called Cinnechol™ (http://www.cinnechol.com), that offers a complementary and/or alternative solution to traditional cholesterol drugs.
Wed, 09 Apr 2008 14:00:00 PDT - Pieces Coming Together In Parkinson's, Cholesterol Puzzle
In 2006, University of North Carolina at Chapel Hill researchers published a study that found people with low levels of LDL cholesterol are more likely to have Parkinson's disease than people with high LDL levels.But that study could not answer the question of whether low LDL (low-density lipoprotein) levels were present in study participants before they were diagnosed with Parkinson's, or if they developed low LDL levels after being diagnosed.
Sat, 05 Apr 2008 00:00:00 PDT - Levitra® Therapy Suitable For Men With High Cholesterol
At the 23rd Annual European Association of Urology (EAU) Congress, results were presented which added evidence that Levitra® (vardenafil HCI) works very well in men with dyslipidemia.(1) The double-blind, placebo-controlled trial in about 400 men showed that Levitra® significantly improved the ability of men with erectile dysfunction (ED) and high cholesterol, to achieve and maintain an erection for successful sexual intercourse.(2) The trial, led by Dr.
Sat, 05 Apr 2008 00:00:00 PDT - Trans Fat: Why It's Time To Eliminate This Dietary Villain
Trans fats are a cholesterol double whammy. Also known as trans fatty acids, trans fats raise low-density lipoprotein (LDL or "bad") cholesterol and lower high-density lipoprotein (HDL or "good") cholesterol.Experts consider trans fat the worst type of dietary fat. Trans fat contributes to heart disease by promoting low-grade inflammation in the blood vessels. And, trans fats are associated with a higher risk of developing type 2 diabetes.
Fri, 04 Apr 2008 00:00:00 PDT - Sen. Grassley Requests Information On Delay Of Results Of Study On Cholesterol Medication Vytorin
Senate Finance Committee ranking member Chuck Grassley (R-Iowa) on Monday sent a letter to the CEOs of Merck and
Wed, 02 Apr 2008 07:00:00 PDT - Astrazeneca Stops Cholesterol Drug Trial Because Of Promising Results
Pharmaceutical giant AstraZeneca announced yesterday, Monday 31st March, it was stopping the JUPITER clinical trial on its cholesterol-busting drug Crestor (rosuvastatin calcium) because early findings showed that the drug reduced deaths and risk of heart problems in patients compared to placebo.
Tue, 01 Apr 2008 11:00:00 PDT - Merck/Schering-Plough Pharmaceuticals Comments On Results Of The ENHANCE Study
Results of ENHANCE (Ezetimibe aNd simvastatin in Hypercholesterolemia enhANces atherosClerosis rEgression), an imaging trial in 720 patients with heterozygous familial hypercholesterolemia (HeFH), a rare genetic condition that causes very high levels of LDL "bad" cholesterol and greatly increases
Mon, 31 Mar 2008 00:00:00 PDT - Phoenix Marketing Study Demonstrates Impact Of Press Coverage And Advertising On Cholesterol Drug Users And Medication Brands
A burst of unfavorable or confusing publicity often prompts users of prescription medications to take swift actions that can hurt those medications' brand perception and market share, according to researchers at Phoenix Healthcare, a Phoenix Marketing International practice.
Fri, 28 Mar 2008 16:00:00 PDT - Karo Bio Strengthens Eprotirome Phase II Program With Additional Clinical Study
Karo Bio initiates the second clinical phase IIb dose ranging study with eprotirome. This study will be conducted in dyslipidemia patients receiving concomitant treatment with the cholesterol absorption inhibitor ezetimibe. The first phase IIb study in 180 patients where eprotirome is given in addition to statin treatment is progressing according to plan. Karo Bio's compound eprotirome is a novel, selective, thyroid hormone agonist for treatment of dyslipidemia.
Fri, 28 Mar 2008 10:00:00 PDT - Daily Consumption Of CocoaVia Dark Chocolate Bars Significantly Lowered Cholesterol Levels And Systolic Blood Pressure In Study Participants
Daily consumption of chocolate bars made with a patented combination of plant sterols and cocoa flavanols may affect cardiovascular risk by lowering elevated cholesterol levels and improving blood pressure, according to a new study published in the Journal of Nutrition.
Thu, 27 Mar 2008 05:00:00 PDT - VAP Test Helps Researchers Uncover Best Cholesterol Lowering Treatment For Type II Diabetes
The VAP cholesterol test from Atherotech is helping physicians pinpoint the most effective cholesterol and heart disease risk lowering treatments in Type II diabetes patients, providing valuable and potentially lifesaving information to diabetics and the doctors who treat them.
Wed, 26 Mar 2008 00:00:00 PDT - Cholesterol-Associated Gene Variants Can Predict Cardiovascular Events
A study appearing in this week's New England Journal of Medicine confirms that a combination of gene variants previously associated with cholesterol levels does reflect patients' cholesterol levels and can signify increased risk of heart attack, stroke or sudden cardiac death.
Fri, 21 Mar 2008 05:00:00 PDT - Lloydspharmacy Study Shows The Average UK Heart Is Five Years Older Than Its Owner
Based on an analysis of heart health checks conducted at branches of Lloydspharmacy, and using a protocol developed by Unilever and Boston University, the study shows that people's hearts are aging faster than they should. The research is based on a sample of more than 3000 tests conducted on adults less than 60 years old. The study should be a real wake up call for smokers in particular.
Mon, 17 Mar 2008 02:00:00 PDT
